TOKYO (Reuters) - Japan could offer an unapproved drug under certain circumstances to help treat the deadly Ebola virus even before the World Health Organization has decided to make a request for the drug, the country's top government spokesman said on Monday.
Chief Cabinet Secretary Yoshihide Suga told a news conference that Japan would cooperate with the WHO and was ready to make an international contribution.
"I am informed that medical professionals could make a request for T-705 in an emergency even before a decision by the WHO. In that case, we would like to respond under certain criteria," he said.
T-705 is the developmental code for the influenza drug favipiravir. Japan's Fujifilm Holdings Corp and U.S. partner MediVector are in talks with the U.S. Food and Drug Administration to submit an application to expand the use of favipiravir as a treatment for Ebola.
The Ebola epidemic in West Africa has killed more than 1,000 people and prompted the WHO to declare an international health emergency.
(Reporting by Kaori Kaneko; Editing by Chris Gallagher)
WaPo editorial writer about to become very unpopular with #BlackLivesMatter - Hot Air
Mt. McKinley Is Still There | RedState
Small But Honest Columnist Again Forced to Correct Highest-Rated Show on Cable TV | Human Events
Nick Adams - Not a Single Illegal Immigrant in 7 Months... In Australia
Arkansas Open Carrier Convicted - Bearing Arms - Arkansas, open carry
S. E. Cupp - Blame Liberals for the Rise of Trump
Kanye West announces he is running for president in 2020 #VMAs [vine]